Rossell, Susan

Prof Susan Rossell

Professor of Eating Disorders, InsideOut Institute, Faculty of Medicine and Health, University of Sydney; Honorary Professorial Fellow in Psychiatry, St Vincent's Hospital, Melbourne; Co-Chair of MAGNET; Professor of Cognitive Neuropsychology and Director of Clinical Trials, Swinburne University of Technology
Susan Rossell is Professor of Eating Disorders at InsideOut Institute, Faculty of Medicine and Health, University of Sydney, and Honorary Professorial Fellow in Psychiatry at St Vincent’s Hospital, Melbourne. She also serves as Co-Chair of MAGNET, the Australian mental health clinical trial network, and is Professor of Cognitive Neuropsychology and Director of Clinical Trials at Swinburne University of Technology.

As a research-focused academic, she is a world-leading clinical trialist and neuropsychologist in the field of body image and eating disorders. From 2018-2023, SciVal ranked her within the top 5% globally for her research on “cognitive dysfunction” in mental health. ExpertScape and Scopus rank her #1 globally in body dysmorphic disorder (BDD) and #1 in Australia (and #5 globally) for cognition.

Professor Rossell trained at the University of Manchester and King’s College London, and held a lectureship at the University of Oxford prior to moving to Australia. She has since held academic and research positions at Macquarie University, University of Melbourne, and Monash University.

More from this expert

InsideOut presents an episode on recognising body dysmorphic disorder (BDD) with a focus on men, LGBTQI+ communities, and athletes. Join Prof Susan Rossell and Dr Karen Spielman as they unpack practical pathways for early intervention and referral.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.